Research in Meldola
Science Explorer records 2 research institutions in Meldola, Italy. The highest-ranked on research quality in 2022–2025 are Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori.
- Research institutions
- 2 1 of them ranked worldwide
- Research works
- 1.3k ▲ 73% vs 2013–17
- Top-10% rate, 2022–2025
- 20.0% record average 16.5%
A city carries no overall standing here. The composite score is built for institutions and countries, the units its floors and field normalisation were designed around. An empty rank on this page is a statement about the measure, not about the place.
Which research institutions are in Meldola?
| # | Institution | Works | Against the largest here | World rank |
|---|---|---|---|---|
| 1 | Istituto Scientifico Romagnolo per lo Studio e la Cura dei TumoriResearch facility | 1,328 | #9,554 | |
| 2 | Vittorio Tison AssociationInstitution | 0 | not ranked |
By fractional works over the whole record; world rank on research quality in 2022–2025. Bars are scaled to the largest institution in this city, not to anything off the page.
What is Meldola strongest at in research?
Relative to its size, research in Meldola is most concentrated in Oncology and Pulmonary and Respiratory Medicine (17.4× the world share in Oncology).
- OncologySubfield · 51.6 works17×
- Pulmonary and Respiratory MedicineSubfield · 34.4 works8.5×
Location quotient against the world baseline. Inside a single field a city is a meaningful unit, which is why this is where a city is measured at all.
Which keywords describe research in Meldola?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Prognostic Factors, Targeted Therapy, Clinical Trials, Tumor Microenvironment, Biomarkers and Genetic Mutations.
- Hematopoietic Stem Cells
- Neoadjuvant Therapy
- Molecular Biology
- Androgen Receptor
- Metastatic Breast Cancer
- Mutational Signatures
- Somatic Mutations
- International Myeloma Working Group
- PET Imaging
- Immune Checkpoint Blockade
- Staging System
- Minimal Residual Disease
- Cancer Therapy
- Prostate Cancer
- Clinical Practice Guidelines
- Breast Cancer
- Biomarkers
- Cancer
- Clinical Trials
- Immunotherapy
- Chemotherapy
- Prognostic Factors
- Targeted Therapy
- Tumor Microenvironment
- Genetic Mutations
- Genomic Profiling
- Metastasis
- Survival Analysis
- Precision Medicine
- Proteasome Inhibitors
- Genomic Instability
- PD-1 and PD-L1
- Diagnosis Criteria
- Radiotherapy
- Cancer Genomics
- Hormone Therapy
- Molecular Subtypes
- Metastatic Prostate Cancer
- Molecular Characterization
- Cancer Immunotherapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this city's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy27▲ 15×21 topics
- Immunotherapy26▲ 14×18 topics
- Prognostic Factors24▲ 21×14 topics
- Clinical Trials20▲ 11×12 topics
- Targeted Therapy20▲ 34×4 topics
- Cancer17▲ 4.9×35 topics
- Tumor Microenvironment17▲ 14×8 topics
- Biomarkers16▲ 8.8×11 topics
- Genetic Mutations14▲ 12×11 topics
- Breast Cancer14▲ 22×10 topics
- Genomic Profiling13▲ 47×2 topics
- Clinical Practice Guidelines12▲ 8.4×12 topics
- Metastasis12▲ 13×9 topics
- Prostate Cancer12▲ 34×4 topics
- Survival Analysis11▲ 16×6 topics
- Cancer Therapy10▲ 6.9×12 topics
- Precision Medicine10▲ 8.5×7 topics
- Minimal Residual Disease10▲ 56×2 topics
- Proteasome Inhibitors10▲ 53×2 topics
- Staging System9▲ 58×2 topics
- Genomic Instability9▲ 31×3 topics
- Immune Checkpoint Blockade9▲ 31×1 topic
- PD-1 and PD-L19▲ 31×1 topic
- PET Imaging9▲ 20×5 topics
- Diagnosis Criteria9▲ 92×1 topic
- International Myeloma Working Group9▲ 92×1 topic
- Radiotherapy8▲ 8.4×12 topics
- Somatic Mutations8▲ 37×2 topics
- Cancer Genomics8▲ 41×1 topic
- Mutational Signatures8▲ 41×1 topic
- Hormone Therapy8▲ 36×3 topics
- Metastatic Breast Cancer8▲ 52×2 topics
- Molecular Subtypes8▲ 35×3 topics
- Androgen Receptor8▲ 40×2 topics
- Metastatic Prostate Cancer8▲ 71×1 topic
- Molecular Biology8▲ 70×1 topic
- Molecular Characterization7▲ 16×5 topics
- Neoadjuvant Therapy7▲ 11×5 topics
- Cancer Immunotherapy7▲ 17×3 topics
- Hematopoietic Stem Cells7▲ 29×3 topics
What research is done in Meldola?
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 9 works
- 2 Multiple Myeloma Research and Treatments Hematology 9 works
- 3 Cancer Genomics and Diagnostics Cancer Research 8 works
- 4 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 8 works
- 5 Acute Myeloid Leukemia Research Hematology 6 works
- 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 5 works
- 7 Colorectal Cancer Treatments and Studies Oncology 5 works
- 8 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 5 works
- 9 Chronic Lymphocytic Leukemia Research Genetics 4 works
- 10 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 4 works
Research output over time
The same series as a ribbon — one cell per year, darker for more.